Vanguard Capital Management
TMDX icon

Vanguard Capital Management’s Transmedics TMDX Stock Holding History

Vanguard Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.5M Buy
1,497,600
+19,448
+1% +$1.65M ﹤0.01% 1556
2026
Q1 		$147M Buy
+1,478,152
New +$193M ﹤0.01% 1258

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management's TMDX Position: Q2 2026 in Review

Vanguard Capital Management increased its Transmedics (TMDX) stake by 1.3% in Q2 2026, buying an estimated $1.65M and bringing the position to 1,497,600 shares worth $99.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1556.

Vanguard Capital Management first reported a position in TMDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $147M in Q1 2026. 368 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Vanguard Capital Management held 1,497,600 shares of Transmedics worth $99.5M as of Q2 2026.
  • Vanguard Capital Management bought 19,448 Transmedics shares in Q2 2026, an estimated $1.65M.
  • Transmedics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1556 holding.
  • Vanguard Capital Management first reported a position in Transmedics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Transmedics position peaked at $147M in Q1 2026.
  • 368 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.